CME Group Inc. (CME) Insider Kimberly S. Taylor Sells 2,300 Shares
CME Group Inc. (NASDAQ:CME) insider Kimberly S. Taylor sold 2,300 shares of the business’s stock in a transaction dated Thursday, September 29th. The shares were sold at an average price of $106.01, for a total transaction of $243,823.00. Following the completion of the transaction, the insider now directly owns 105,558 shares of the company’s stock, valued at approximately $11,190,203.58. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink.
Shares of CME Group Inc. (NASDAQ:CME) opened at 104.52 on Friday. CME Group Inc. has a 12 month low of $81.87 and a 12 month high of $110.35. The firm has a 50-day moving average of $106.83 and a 200 day moving average of $99.14. The firm has a market cap of $35.42 billion, a P/E ratio of 26.39 and a beta of 0.85.
CME Group (NASDAQ:CME) last released its quarterly earnings data on Thursday, July 28th. The company reported $1.14 EPS for the quarter, beating analysts’ consensus estimates of $1.11 by $0.03. The business earned $906 million during the quarter, compared to the consensus estimate of $897.84 million. CME Group had a return on equity of 6.83% and a net margin of 38.22%. The firm’s revenue was up 10.5% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.95 earnings per share. On average, equities research analysts anticipate that CME Group Inc. will post $4.44 EPS for the current fiscal year.
The business also recently disclosed a quarterly dividend, which was paid on Monday, September 26th. Investors of record on Friday, September 9th were issued a $0.60 dividend. The ex-dividend date was Wednesday, September 7th. This represents a $2.40 dividend on an annualized basis and a yield of 2.30%. CME Group’s dividend payout ratio is presently 60.61%.
A number of large investors have recently added to or reduced their stakes in CME. Vanguard Group Inc. increased its stake in shares of CME Group by 2.1% in the second quarter. Vanguard Group Inc. now owns 20,131,757 shares of the company’s stock valued at $1,960,833,000 after buying an additional 406,686 shares during the period. Capital International Investors increased its stake in shares of CME Group by 1.8% in the second quarter. Capital International Investors now owns 11,079,915 shares of the company’s stock valued at $1,079,184,000 after buying an additional 197,881 shares during the period. BlackRock Institutional Trust Company N.A. increased its stake in shares of CME Group by 4.5% in the second quarter. BlackRock Institutional Trust Company N.A. now owns 10,092,373 shares of the company’s stock valued at $982,997,000 after buying an additional 431,255 shares during the period. BlackRock Fund Advisors increased its stake in shares of CME Group by 6.8% in the second quarter. BlackRock Fund Advisors now owns 9,073,017 shares of the company’s stock valued at $883,712,000 after buying an additional 577,672 shares during the period. Finally, JPMorgan Chase & Co. increased its stake in shares of CME Group by 3.7% in the second quarter. JPMorgan Chase & Co. now owns 6,976,489 shares of the company’s stock valued at $679,507,000 after buying an additional 249,481 shares during the period. Institutional investors and hedge funds own 80.29% of the company’s stock.
Several brokerages recently weighed in on CME. Zacks Investment Research raised shares of CME Group from a “hold” rating to a “buy” rating and set a $116.00 target price for the company in a research note on Thursday, August 4th. Jefferies Group boosted their target price on shares of CME Group from $112.00 to $118.00 and gave the company a “buy” rating in a research note on Wednesday, August 31st. Barclays PLC cut their target price on shares of CME Group from $100.00 to $99.00 and set an “equal weight” rating for the company in a research note on Friday, July 29th. JPMorgan Chase & Co. set a $116.00 price objective on shares of CME Group and gave the company a “buy” rating in a research note on Monday, September 12th. Finally, Keefe, Bruyette & Woods upped their price objective on shares of CME Group from $99.00 to $103.00 and gave the company a “market perform” rating in a research note on Friday, July 29th. Two investment analysts have rated the stock with a sell rating, six have given a hold rating and six have assigned a buy rating to the company’s stock. CME Group presently has a consensus rating of “Hold” and a consensus price target of $102.89.
CME Group Company Profile
CME Group Inc is a provider of products across all major asset classes, based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals. The Company’s products include both exchange-traded and privately negotiated futures and options contracts and swaps. The Company connects buyers and sellers together through its CME Globex electronic trading platform across the globe and its open outcry trading facilities in Chicago and New York City.
Receive News & Stock Ratings for CME Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc. and related stocks with our FREE daily email newsletter.